111

ALLIED BIOTECH COR

No trades
See on Supercharts

1780 fundamentals

An in-depth look to ALLIED BIOTECH COR operating, investing, and financing activities

1780 free cash flow for H2 23 is 44.31 M TWD. For 2023, 1780 free cash flow was 89.5 M TWD and operating cash flow was 137.41 M TWD.

‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
TTM
Free cash flowYoY growth